Skip to content

Clinical trials

Completed Multiple Sclerosis, Relapsing-Remitting trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Completed Country / region: Denmark Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20072
20082
20092
20101
20112
20121
20141
20151
20161
20181
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen4
Genzyme, a Sanofi Company3
Bayer2
Danish Research Centre for Magnetic Resonance1
EMD Serono Research & Development Institute, Inc.1
Genentech, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
Merck KGaA, Darmstadt, Germany1
Rigshospitalet, Denmark1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting17
Multiple Sclerosis6
Multiple Sclerosis, Chronic Progressive2
Fatigue1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.